Abstract
The prevention of malaria infections is one of the most important functions that any clinician can perform for those traveling to tropical geographic regions where malaria risks are present. The prophylaxis question has become complicated by continued emergence of chloroquine-resistant strains of Plasmodium falciparum, the recent appearance of Plasmodium vivax resistance, and the availability of a wide choice of antimalarial pharmaceuticals. Chemoprophylaxis may produce different toxicities among various patient populations. With increasing numbers of women who travel during their professional lives, there are potential implications for using chemoprophylaxis during pregnancy. Children are unable to tolerate certain antimalarials because of toxicities unique for them. In some instances, the safest and most palatable formulations for children are not even available in the United States and must be purchased in Canada or elsewhere. Reliance upon chemoprophylaxis alone has proven to be increasingly futile. With the introduction of new repellent formulations and nontoxic insecticides for use on clothing or bed netting, there are non-pharmacologic adjunctive measures which can now be considered first-line for the prevention of malaria infections.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barry M. Medical considerations for international travel with infants and older children. Infect Dis Clin North Am. 1992 Jun;6(2):389–404. [PubMed] [Google Scholar]
- Barry M., Patterson J. E., Tirrell S., Cullen M. R., Shope R. E. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1991 Jan;44(1):79–82. doi: 10.4269/ajtmh.1991.44.79. [DOI] [PubMed] [Google Scholar]
- Bia F. J. Medical considerations for the pregnant traveler. Infect Dis Clin North Am. 1992 Jun;6(2):371–388. [PubMed] [Google Scholar]
- COATNEY G. R. Pitfalls in a discovery: the chronicle of chloroquine. Am J Trop Med Hyg. 1963 Mar;12:121–128. doi: 10.4269/ajtmh.1963.12.121. [DOI] [PubMed] [Google Scholar]
- Herwaldt B. L., Krogstad D. J., Schlesinger P. H. Antimalarial agents: specific chemoprophylaxis regimens. Antimicrob Agents Chemother. 1988 Jul;32(7):953–956. doi: 10.1128/aac.32.7.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krotoski W. A. Frequency of relapse and primaquine resistance in Southeast Asian vivax malaria. N Engl J Med. 1980 Sep 4;303(10):587–587. doi: 10.1056/NEJM198009043031022. [DOI] [PubMed] [Google Scholar]
- Lobel H. O., Bernard K. W., Williams S. L., Hightower A. W., Patchen L. C., Campbell C. C. Effectiveness and tolerance of long-term malaria prophylaxis with mefloquine. Need for a better dosing regimen. JAMA. 1991 Jan 16;265(3):361–364. [PubMed] [Google Scholar]
- Pang L. W., Limsomwong N., Singharaj P., Canfield C. J. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area. Bull World Health Organ. 1989;67(1):51–58. [PMC free article] [PubMed] [Google Scholar]
- Patterson J. E., Bia F. J., Miller K., McPhedran P. Relapsing malaria infection acquired in Kenya. Yale J Biol Med. 1987 May-Jun;60(3):245–253. [PMC free article] [PubMed] [Google Scholar]
- Procacci P. G., Lamizana L., Kumlien S., Habluetzel A., Rotigliano G. Permethrin-impregnated curtains in malaria control. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):181–185. doi: 10.1016/0035-9203(91)90013-o. [DOI] [PubMed] [Google Scholar]